SART

BIVF Foundation Empowers Parenthood Aspirations with 2023 Family Building and Fertility Grants

Retrieved on: 
Wednesday, November 8, 2023

BOSTON, Nov. 8, 2023 /PRNewswire-PRWeb/ -- The BIVF Foundation, a recently established 501(c)(3) non-profit organization dedicated to aiding individuals and couples seeking fertility treatments and family building services, proudly announces the launch of its 2023 fertility and family building grant program. This pioneering organization is resolute in its mission to eliminate obstacles to parenthood, ensuring that fertility treatments and family-building resources are within reach for those grappling with financial constraints due to inadequate insurance coverage.

Key Points: 
  • BOSTON, Nov. 8, 2023 /PRNewswire-PRWeb/ -- The BIVF Foundation, a recently established 501(c)(3) non-profit organization dedicated to aiding individuals and couples seeking fertility treatments and family building services, proudly announces the launch of its 2023 fertility and family building grant program.
  • At the heart of the BIVF Foundation's mission lies its 2023 flagship program, the Family Building Grants.
  • These grants represent a groundbreaking initiative aimed at providing vital financial support to individuals and couples in need of fertility treatment and family building services.
  • Through their Family Building Grants, they reaffirm the belief that parenthood is an achievable dream.

Clinics within The Prelude Network ® Recognized by the Society for Assisted Reproductive Technology for Excellence in Fertility Care Services and Reporting

Retrieved on: 
Tuesday, November 7, 2023

HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.

Key Points: 
  • HOUSTON, Nov. 7, 2023 /PRNewswire/ -- The Prelude Network ®, the largest network of fertility clinics in North America, announces today that two of its clinics have been recognized by the Society for Assisted Reproductive Technology (SART), with Reproductive Biology Associates (RBA) in Atlanta, Georgia receiving a SART Platinum designation and IVFMD in Miami, Florida receiving a SART Gold designation.
  • This recognition is a joint selection by SART's Quality Assurance and Validation Committees to recognize clinics for their excellence in prospective reporting and for following guidance set forth by the American Society for Reproductive Medicine (ASRM) and SART.
  • "It is a testament of their dedication to patients and the field of reproductive medicine to uphold, practice, and deliver the highest standards in fertility care."
  • The clinic provides patient-centric, individualized care that offers patients the latest science and technologies in fertility medicine.

Leading the Way in ADHD Care: Creyos Health Introduces a New Online Protocol to Enhance Precision in ADHD Detection

Retrieved on: 
Wednesday, October 25, 2023

The 25-minute, patient-friendly assessment combines relevant online tasks from the Creyos cognitive battery that researchers determined are sensitive to known signs of ADHD.

Key Points: 
  • The 25-minute, patient-friendly assessment combines relevant online tasks from the Creyos cognitive battery that researchers determined are sensitive to known signs of ADHD.
  • Healthcare providers testing for ADHD can assign the protocol from within their Creyos account for patients to complete in-clinic or remotely.
  • "In developing the ADHD protocol and report at Creyos, we followed the data,'' noted Dr. Adrian Owen OBE, renowned neuroscientist and Chief Scientific Officer at Creyos.
  • The Creyos ADHD protocol and report are now available for all Creyos customers and come standard as part of every Creyos subscription.

Chief Research Officer at US Fertility, Kate Devine, M.D., receives prestigious award from ASRM

Retrieved on: 
Wednesday, October 18, 2023

LOS ANGELES, Oct. 18, 2023 /PRNewswire-PRWeb/ -- US Fertility celebrates, Kate Devine, M.D., Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.

Key Points: 
  • , Medical Director and Chief Research Officer, who received the Ira and Ester Rosenwaks New Investigator Award of the American Society for Reproductive Medicine for 2023.
  • "I am incredibly humbled to receive such an honor and send gratitude to ASRM and my physician peers who have supported me," shares Dr. Devine.
  • The award was announced during ASRM's Opening Ceremony on Monday, October 16, 2023 and presented during the ASRM Research Symposium on Wednesday, October 18, 2023.
  • Learn more about US Fertility's Research Division , which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.

GoGold Updates on Parral Zinc Circuit and Reports Parral Production

Retrieved on: 
Tuesday, October 17, 2023

HALIFAX, NS, Oct. 17, 2023 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") announces production for the quarter ending September 30, 2023.

Key Points: 
  • HALIFAX, NS, Oct. 17, 2023 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") announces production for the quarter ending September 30, 2023.
  • Production was impacted as a result of the rehandling program, as the rehandled material was a lower grade than stacking new material.
  • Production during the quarter was 300,789 silver equivalent ounces, consisting of 169,443 silver ounces, 1,106 gold ounces, and 115 tonnes of copper.
  • Construction of a zinc circuit addition to the SART plant at Parral is well underway and projected to be completed by the end of this year, with the project on budget and on schedule.

Life Whisperer Genetics AI launches in the USA: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, and Affordable Technology

Retrieved on: 
Friday, October 13, 2023

Life Whisperer Genetics: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, & Affordable Technology

Key Points: 
  • Life Whisperer Genetics: Revolutionizing Embryo Euploidy Assessment with Non-Invasive, Instant, & Affordable Technology
    Euploid embryos are selected for use in IVF as they are reported to have improved pregnancy and live birth outcomes.
  • Current approaches to assessing embryo euploidy include PGT-A, which is costly and requires an invasive biopsy of the embryo.
  • Life Whisperer Genetics allows IVF clinics to non-invasively rank, prioritize, and select good quality embryos based on euploidy with confidence, for confirmatory (PGT-A) testing or for transfer.
  • Life Whisperer is also exhibiting at the ASRM event to showcase Life Whisperer Genetics and its benefits to the local IVF fertility industry.

Stork Club Announces Partnership with Nevada Fertility Center

Retrieved on: 
Wednesday, September 13, 2023

SAN FRANCISCO, Sept. 13, 2023 /PRNewswire/ -- Stork Club, a pioneering family-building benefits solution, today announced its partnership with Nevada Fertility Center, the leading fertility center in the Vegas Market.

Key Points: 
  • SAN FRANCISCO, Sept. 13, 2023 /PRNewswire/ -- Stork Club , a pioneering family-building benefits solution, today announced its partnership with Nevada Fertility Center , the leading fertility center in the Vegas Market.
  • The partnership between Stork Club and Nevada Fertility Center arrives at a critical time in fertility healthcare, as escalating healthcare expenses and alarming rates of maternal mortality contribute to a pressing health and equity crisis.
  • The team at Nevada Fertility Center includes:
    "I am thrilled to announce the partnership between Stork Club and Nevada Fertility Center, which signifies a transformative milestone in fertility healthcare," said Stork Club founder and CEO Jeni Mayorskaya.
  • This partnership announcement comes on the heels of Stork Club's recent partnership with Neway Fertility and Utah Fertility Center .

GoGold Releases Financial Results for Quarter Ending June 30, 2023

Retrieved on: 
Wednesday, August 9, 2023

HALIFAX, NS, Aug. 9, 2023 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") announces the financial results for the quarter ending June 30, 2023, including net income of $2.6 million (all amounts are in U.S. dollars) and Parral generating $8.6 million from the sale of 360,011 silver equivalent ounces.

Key Points: 
  • HALIFAX, NS, Aug. 9, 2023 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") announces the financial results for the quarter ending June 30, 2023, including net income of $2.6 million (all amounts are in U.S. dollars) and Parral generating $8.6 million from the sale of 360,011 silver equivalent ounces.
  • "GoGold maintains a strong balance sheet with $98.7 million USD in cash which continues to allow us to advance our Los Ricos projects in an expeditious manner.
  • Our main focus at GoGold is our flagship assets at Los Ricos.
  • The savings and additional revenue which the zinc circuit will provide should significantly reduce our all in sustaining cost at Parral," said Brad Langille, President and CEO.

GoGold Reports Parral Production for Quarter Ending June 2023 and Reports on Planned Zinc Circuit

Retrieved on: 
Wednesday, July 12, 2023

HALIFAX, NS, July 12, 2023 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") is pleased to report production for the quarter ending June 30, 2023 of 375,112 silver equivalent ounces, consisting of 203,894 silver ounces, 1,512 gold ounces, and 135 tonnes of copper.

Key Points: 
  • HALIFAX, NS, July 12, 2023 /PRNewswire/ - GoGold Resources Inc. (TSX: GGD) (OTCQX: GLGDF) ("GoGold", "the Company") is pleased to report production for the quarter ending June 30, 2023 of 375,112 silver equivalent ounces, consisting of 203,894 silver ounces, 1,512 gold ounces, and 135 tonnes of copper.
  • Our expectation is the circuit will generate an additional $1.5 million in cash flows per quarter after the circuit is completed," said Brad Langille, President and CEO.
  • With that being said, we are now in our tenth year of production at our Parral operation, with a remaining seven years ahead of us.
  • The addition of a zinc circuit is another way that Parral can remain a meaningful contributor of revenue over its remaining mine life.

Expanding Access to Women’s Health Fresenius Kabi Launches Generic Fertility Treatment

Retrieved on: 
Monday, July 10, 2023

Fresenius Kabi announced today it has launched Ganirelix Acetate Injection, a generic fertility drug, as part of the company’s expansion in women’s health.

Key Points: 
  • Fresenius Kabi announced today it has launched Ganirelix Acetate Injection, a generic fertility drug, as part of the company’s expansion in women’s health.
  • Ganirelix Acetate Injection is available immediately from Fresenius Kabi in 250 mcg/0.5 mL prefilled syringes.
  • View the full release here: https://www.businesswire.com/news/home/20230710582430/en/
    Now available: Fresenius Kabi Ganirelix Acetate Injection.
  • Ganirelix Acetate Injection is the third product offering in Fresenius Kabi’s Women’s Health portfolio, which includes Chorionic Gonadotropin for Injection, USP (hCG) and Progesterone Injection, USP.